Skip to Content

GX CG5 (Lamivudine 100 mg)

Pill with imprint GX CG5 is Brown, Capsule-shape and has been identified as Lamivudine 100 mg. It is supplied by Prasco Laboratories.

Lamivudine is used in the treatment of hepatitis b; nonoccupational exposure; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GX CG5

Lamivudine

Imprint:
GX CG5
Strength:
100 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Prasco Laboratories
National Drug Code (NDC):
66993-0478

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide